EUVIMEDEUVIMED entdecken
Crossref

Cryopreservation as an Alternative Approach for Applying Photopheresis Products to Treat Graft‐Versus‐Host Disease ( GVHD ) Among Pediatric Patients in Developing Countries

Leila Jafari, Pooya Ashkevari, Sarina Ansari, Mona Delkhah, Yalda Karamlou, Nika Asephi, Homa Kashani, Rashin Mohseni, Hamid Farajifard, Mohamad Taha Salmanifard, Fahimeh Jafari, Maryam Behfar und 1 weitere

Pediatric Transplantation · 2025

DOI: 10.1111/petr.70208 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Transplantation, 2025. Verfasst von Leila Jafari und 12 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Cell and Gene Therapy Research Centre, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Graft vs Host Disease, Photopheresis, Cryopreservation. Die Arbeit nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

A significant challenge in extracorporeal photopheresis (ECP) in developing countries is the high cost of apheresis equipment. Additionally, obtaining proper IV access in pediatric patients is considerably more difficult than in adult patients. To address the limitations of applying ECP for pediatric patients, such as vein access difficulties, time constraints, and costs, the cryopreservation of mononuclear cells (MNCs) has been explored. Since cryopreservation reduces the need for repeated apheresis procedures, it offers potential convenience for pediatric patients and resource‐limited settings, particularly in developing countries. Study Design and Methods Twenty‐four pediatric patients with steroid‐resistant or steroid‐dependent acute or chronic GvHD participated in this study. All patients underwent offline apheresis. The viability and proliferation rates of fresh and thawed MNCs were assessed using flow cytometry and the CFSE assay. The clinical response was also evaluated at various time points over 21 months for all patients.

Results

There were no significant differences in annexin/PI analysis ( p = 0.39) and CFSE assay ( p = 0.8) between fresh and thawed samples using flow cytometry. Response to ECP after nine months in aGvHD revealed favorable results, with a complete response in 12 patients (60%) and a partial response in 8 patients (40%), which remained stable until 12 months after ECP therapy. In cGvHD, complete and partial responses were the same and occurred in 7 patients (46.6%).

Conclusion

Cryopreserving MNCs for ECP in pediatric patients with steroid‐resistant GvHD is a practical and effective method to overcome existing limitations. We propose that cryopreservation could be a more effective option than repeated apheresis for pediatric patients and in developing countries, as it reduces costs and eliminates the need for multiple apheresis sessions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft vs Host DiseasePhotopheresisCryopreservationHumansChildMaleDeveloping CountriesChild, PreschoolFemaleAdolescentInfantTreatment OutcomeLeukocytes, Mononuclear

Stichwörter der Autor:innen

cryopreservationgraft‐versus‐host diseasehematopoietic stem cell transplantationpediatricsphotopheresis

Autor:innen und Institutionen

  • Pediatric Cell and Gene Therapy Research Centre, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Center for Gene and Cell Therapy, Washington University of St. Louis, Bone Marrow Transplantation of Washington DC, USA.
  • Department of Research Methodology and Data Analysis, Institute for Environmental Research, Tehran, University of Medical Sciences, Tehran, Iran.
  • Tehran University of Medical Sciences, Children's Medical Center, Tehran, Iran.

ORCID-Profile: Amir Ali Hamidieh

Zitieren

APA

Jafari, L., Ashkevari, P., Ansari, S., Delkhah, M., Karamlou, Y., Asephi, N., Kashani, H., Mohseni, R., Farajifard, H., Salmanifard, M. T., Jafari, F., Behfar, M., & Hamidieh, A. A. (2025). Cryopreservation as an Alternative Approach for Applying Photopheresis Products to Treat Graft‐Versus‐Host Disease ( GVHD ) Among Pediatric Patients in Developing Countries. Pediatric Transplantation. https://doi.org/10.1111/petr.70208

Vancouver

Jafari L, Ashkevari P, Ansari S, Delkhah M, Karamlou Y, Asephi N, et al. Cryopreservation as an Alternative Approach for Applying Photopheresis Products to Treat Graft‐Versus‐Host Disease ( GVHD ) Among Pediatric Patients in Developing Countries. Pediatric Transplantation. 2025. doi:10.1111/petr.70208

BibTeX
@article{Jafari2025,
  author = {Jafari, Leila and Ashkevari, Pooya and Ansari, Sarina and Delkhah, Mona and Karamlou, Yalda and Asephi, Nika and Kashani, Homa and Mohseni, Rashin and Farajifard, Hamid and Salmanifard, Mohamad Taha and Jafari, Fahimeh and Behfar, Maryam and Hamidieh, Amir Ali},
  title = {Cryopreservation as an Alternative Approach for Applying Photopheresis Products to Treat Graft‐Versus‐Host Disease ( GVHD ) Among Pediatric Patients in Developing Countries},
  journal = {Pediatric Transplantation},
  year = {2025},
  doi = {10.1111/petr.70208}
}
Kostenlos starten →